000 01572 a2200445 4500
005 20250517081238.0
264 0 _c20171222
008 201712s 0 0 eng d
022 _a1029-2403
024 7 _a10.3109/10428194.2016.1141406
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDrachtman, Richard A
245 0 0 _aLong-term outcomes for children with acute lymphoblastic leukemia (ALL) treated on The Cancer Institute of New Jersey ALL trial (CINJALL).
_h[electronic resource]
260 _bLeukemia & lymphoma
_c10 2016
300 _a2275-80 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aConsolidation Chemotherapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aMethylenetetrahydrofolate Reductase (NADPH2)
_xgenetics
650 0 4 _aPolymorphism, Genetic
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdiagnosis
650 0 4 _aRecurrence
650 0 4 _aRemission Induction
650 0 4 _aTesticular Neoplasms
_xsecondary
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aMasterson, Margaret
700 1 _aShenkerman, Angela
700 1 _aVijayanathan, Veena
700 1 _aCole, Peter D
773 0 _tLeukemia & lymphoma
_gvol. 57
_gno. 10
_gp. 2275-80
856 4 0 _uhttps://doi.org/10.3109/10428194.2016.1141406
_zAvailable from publisher's website
999 _c25735724
_d25735724